Pacira | PCRX - Ebitda





Ebitda تغيير تاريخ
Astellas Pharma JPY 235.24B 136.32B 2026-06
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Cara Therapeutics USD -2.39M 3.16M 2025-03
Coherus Biosciences USD -43.33M 4.7M 2025-09
Heron Therapeutics USD -3.88M 5.63M 2024-09
Ironwood Pharmaceuticals USD 81.81M 31.71M 2025-09
J&J USD 8.27B 1.08B 2026-03
Ligand Pharmaceuticals USD -14.3M 81.08M 2026-03
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Novo Nordisk DKK 37.36B 2.64B 2026-06
Omeros USD -47.96M 7.39M 2023-09
Pacira USD 48.67M 8.43M 2026-06
Perrigo USD 141.6M 1.34B 2026-03
Pfizer USD 6.01B 18M 2026-06
Supernus Pharmaceuticals USD 31.6M 2.37M 2026-06
Teva Pharmaceutical Industries USD 474M 581M 2026-06
Xeris Pharmaceuticals USD 12.33M 12.76M 2026-03
Zoetis USD 939M 0 2026-03